Aurinia Pharmaceuticals (AUPH) Beats Q4 Earnings and Revenue Estimates

Aurinia Pharmaceuticals (AUPH) came out with quarterly earnings of $0.09 per share, beating the Zacks Consensus Estimate of$ 0.03 per share. This compares to loss of $0.19 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 200%. A quarter ago, it was expected that this biotechnology company would post earnings of$ 0.02 per share when it actually produced earnings of $0.10, delivering a surprise of 400%.Over the last four quarters ...